Benjamin Lindner

Benjamin Lindner

Auto-generated profile, based on publicly available information

Benjamin Lindner

Bioprocess Development Biologicals Cell Line Development Boehringer Ingelheim GmbH & Co. KG Biberach Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2020 in BioTechniques
Verified
Journal Article
Open access
BLBenjamin Lindner
Benjamin Lindner
TBTobias Burkard
Tobias Burkard
MSMichael Schuler
Michael Schuler
Phagocytosis is a fundamental mechanism of innate immunity and its impairment is associated with severe chronic diseases, for example, chronic obstructive pulmonary disease. Investigating phagocyto... METHOD SUMMARY pH-sensitive pHrodo dyes linked to different particles were tested in phagocytosis assays with either a high-content imaging or flow cytometry readout. The live cell kinetics of phag...

21 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BLBenjamin Lindner
Benjamin Lindner
EMEva Martin
Eva Martin
MSMonika Steininger
Monika Steininger
ABAleksandra Bundalo
Aleksandra Bundalo
MLMartin Lenter
Martin Lenter
MSMichael Schuler
Michael Schuler
Phagocytosis of microbial pathogens, dying or dead cells, and cell debris is essential to maintain tissue homeostasis. Impairment of these processes is associated with autoimmunity, developmental defects and toxic protein accumulation. However, the underlying molecular mechanisms of phagocytosis remain incompletely understood. Here, we performed a genome-wide CRISPR knockout screen to systematically identify regulators involved in phagocytosis ofStaphylococcus(S.)aureusby human monocytic THP-1 cells. The screen identified 75 hits including known regulators of phagocytosis, e.g. members of the actin cytoskeleton regulation Arp2/3 and WAVE complexes, as well as genes previously not associated with phagocytosis. These novel genes are involved in translational control (EIF5A and DHPS) and the UDP glycosylation pathway (SLC35A2, SLC35A3, UGCG and UXS1) and were further validated by single gene knockout experiments. Whereas the knockout of EIF5A and DHPS impaired phagocytosis, knocking out SLC35A2, SLC35A3, UGCG and UXS1 resulted in increased phagocytosis. In addition toS. aureusphagocytosis, the above described genes also modulate phagocytosis ofEscherichia coliand yeast-derived zymosan A. In summary, we identified both known and unknown genetic regulators of phagocytosis, the latter providing a valuable resource for future studies dissecting the underlying molecular and cellular mechanisms and their role in human disease.

21 December 2021 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
PDF file
ASAnna Stadermann
Anna Stadermann
MGMartin Gamer
Martin Gamer
JFJürgen Fieder
Jürgen Fieder
BLBenjamin Lindner
Benjamin Lindner
SFSteffen Fehrmann
Steffen Fehrmann
IGIngo H. Gorr
Ingo H. Gorr
Genetically modified CHO cell lines are traditionally used for the production of biopharmaceuticals. However, an in‐depth molecular understanding of the mechanism and exact position of transgene integration into the genome of pharmaceutical manufacturing cell lines is still scarce. Next‐generation sequencing (NGS) holds great promise for strongly facilitating the understanding of CHO cell factories, as it has matured to a powerful and affordable technology for cellular genotype analysis. Targeted Locus Amplification (TLA) combined with NGS allows for robust detection of genomic positions of transgene integration and structural genomic changes occurring upon stable integration of expression vectors. TLA was applied to generate comparative genomic fingerprints of several CHO production cell lines expressing different monoclonal antibodies. Moreover, high producers resulting from an additional round of transfection of an existing cell line (supertransfection) were analyzed to investigate the integrity and the number of integration sites. Our analyses enabled detailed genetic characterization of the integration regions with respect to the number of integrates and structural changes of the host cell's genome. Single integration sites per clone with concatenated transgene copies could be detected and were in some cases found to be associated with genomic rearrangements, deletions or translocations. Supertransfection resulted in an increase in titer associated with an additional integration site per clone. Based on the TLA fingerprints, CHO cell lines originating from the same mother clone could clearly be distinguished. Interestingly, two CHO cell lines originating from the same mother clone were shown to differ genetically and phenotypically despite their identical TLA fingerprints. Taken together, TLA provides an accurate genetic characterization with respect to transgene integration sites compared with conventional methods and represents a valuable tool for a comprehensive evaluation of CHO production clones early in cell line development.

14 March 2023 in New Biotechnology
Verified
Journal Article
Open access
CCChristian Clappier
Christian Clappier
DBDennis Böttner
Dennis Böttner
DHDaniel Heinzelmann
Daniel Heinzelmann
ASAnna Stadermann
Anna Stadermann
PSPatrick Schulz
Patrick Schulz
BLBenjamin Lindner
Benjamin Lindner
Despite advances in genetic characterization of Chinese hamster ovary (CHO) cell lines regarding identification of integration sites using next generation sequencing, e.g. targeted locus amplification sequencing (TLA-seq), the concatemer structure of the integrated vectors remains elusive. Here, the entire integration locus of two CHO manufacturing cell lines was reconstructed combining CRISPR/Cas9 target enrichment, nanopore sequencing and the Canu de novo assembly pipeline. An IgG producing CHO cell line integrated 3 vector copies, which were near full-length and contained all relevant vector elements such as transgenes and their promoters on each of the vector copies. In contrast, a second CHO cell line producing a bivalent bispecific antibody integrated 7 highly fragmented vector copies in different orientations leading to head-to-head and tail-to-tail fusions. The size of the vector fragments ranged from 3.0 to 11.4 kbp each carrying 1-3 transgenes. The breakpoints of the genome-vector and vector-vector junctions were validated using Sanger sequencing and Southern blotting. A comparison to TLA-seq data confirmed the genomic breakpoints, but most of the breakpoints of the vector-vector fusions were missed by TLA-seq. For the first time, the complete transgene locus of CHO manufacturing cell lines could be deciphered. Strikingly, the application of the nanopore long-read sequencing technology led to novel insights into the complexity of genomic transgene integrations of CHO manufacturing cell lines generated via random integration.

7 September 2025 in Biotechnology Journal
Verified
Journal Article
Open access
DHDaniel Heinzelmann
Daniel Heinzelmann
NMNicholas Michelarakis
Nicholas Michelarakis
FRFranziska Reuss
Franziska Reuss
BLBenjamin Lindner
Benjamin Lindner
AKAnne R. Karow‐Zwick
Anne R. Karow‐Zwick
MSMoritz Schmidt
Moritz Schmidt
The use of metabolic selection markers has advanced stable cell line generation, increasing productivity while simultaneously eliminating the need for antibiotic reagents. This study explores the potential of bacterially derived glutamine synthetases (GS) as a novel generation of metabolic selection markers to further enhance CHO cell culture performance. GS‐I proteins were extracted from the genomes of enterobacterial and actinomycetes species. Three of these enzymes demonstrated functionality when stably transfected into GS‐deficient CHO cells, leading to a 3‐ to 4‐fold increase in antibody titer compared to endogenous GS from Cricetulus griseus. This study indicates that the functionality of bacterial GS enzymes in mammalian cells is determined by solvent accessibility and the geometry of the catalytic binding pocket. Dysfunctional variants showed a less accessible bifunnel. Bacterial GS were evaluated for their bioprocess performance leading to superior stable pool and clone performance. Transcriptome analysis further revealed that regulatory cellular mechanisms were decoupled in a cross‐species set‐up, reinforcing the suitability of repurposing bacterial enzymes as selection markers in mammalian cell lines. By modulating the selection stringency, an increase in expression performance was achieved without impairing the bioprocess behavior or long‐term cell line stability.

3 December 2025 in bioRxiv
Verified
Preprint
Open access
DHDaniel Heinzelmann
Daniel Heinzelmann
FRFranziska Reuss
Franziska Reuss
NZNikolas Zeh
Nikolas Zeh
RNRobin Nilson
Robin Nilson
EWEmely Walker
Emely Walker
MSMoritz Schmidt
Moritz Schmidt
Summary: Transposases revolutionized the field of genetic engineering, yet the scarcity of functional systems remains a challenge. In response, we conducted a metagenomic screening and identified a novel transposase system from Acyrthosiphon pisum . Through systematic optimization, we enhanced nuclear localization, transposon composition, and created a hyperactive transposase variant to boost transposition efficiency. Intriguingly, the combined application of the newly discovered transposase with inverted terminal repeat sequences from a related pea aphid species, Aphis craccivora , further enhanced transposition activity, resulting in the first chimeric transposase system reported so far. We investigated the genomic integration events following transposition in mammalian cells, to understand the underlying mechanisms and optimize the efficiency of transgene integration. This optimized system can expedite the generation of recombinant protein producing CHO cell lines, even surpassing the hyperactive piggyBac system with regards to cell specific productivity. These findings introduce a significant addition to the field of semi-targeted transgene integration technologies, offering substantial potential for enhancing biologics manufacturing.